ASTERION RESEARCH & DEVELOPMENT
ActiveSummary
ASTERION RESEARCH & DEVELOPMENT has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.64M and a net result of €-621k. Equity is growing by ~22.6% per year across the filed fiscal years. Its solvency ranks better than 67% of 213 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
Score 2025
61
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability0▼-47
Solvency96▲+74
Growth52▼-26
Track record100
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €100k at 30 days acceptable
Liquidity short (current ratio 0.06 against 1.0 in 2024; short-term debt: 11.5% and cash: 0% of total assets), and 28.7% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Three signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Sector 72
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
71.3%
Return on assets
-26.9%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-07-2026, 7 days ahead of the deadline.
NBB · 8 filingsDeviation from the deadline
2025
7 d early
2024
43 d early
2023
29 d early
2022
122 d late
2021
25 d late
2020
90 d late
2019
202 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€1.64M
2024 · €-16k
2018: €-352k
2019: €-379k
2020: €-431k
2021: €-387k
2022: €-137k
2023: €-53k
2024: €-16k
2018 → 2025
Total assets
€2.31M▲ 304%
2024 · €571k
2018: €132k
2019: €162k
2020: €131k
2021: €163k
2022: €654k
2023: €439k
2024: €571k
2018 → 2025
Net result
€-621k
2024 · €37k
2018: €-359k
2019: €-27k
2020: €-52k
2021: €32k
2022: €250k
2023: €84k
2024: €37k
2018 → 2025
Working capital
€-249k
2024 · €164
2018: €-298k
2019: €-337k
2020: €-367k
2021: €-315k
2022: €-225k
2023: €-300k
2024: €164
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€-387k-€-137k▲ 64.6%€-53k▲ 61.1%€-16k▲ 69.7%€1.64M
Operating result€27k-€203k▲ 641%€93k▼ 54.5%€63k▼ 31.4%€-601k
Net result€32k-€250k▲ 675%€84k▼ 66.5%€37k▼ 55.6%€-621k
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result turns negative in 2025: a loss of €601k after €63k in 2024, the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.31M
Fixed assets
€2.29M ▲ 629%
Current assets
€16k ▼ 93.9%
Equity and liabilities €2.31M
Equity
€1.64M
Debt
€662k
Debt finances 28.7% of the balance-sheet total.
Key figures and ratios
EBITDA
€-596k▼
2024 · €68k
Cash flow
€-616k▼
2024 · €42k
Current ratio
0.06▼
2024 · 1.00
Debt to equity
0.40▲
2024 · -36.36
ROE
-37.8%
ROA
-26.9%▼
2024 · 6.5%
Interest coverage
-25.28▼
2024 · 2.46
Debt ≤ 1 year
€265k▲
2024 · €257k
Debt > 1 year
€397k▲
2024 · €331k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 43 lines
Balance sheet
Code20242025
Assets
Total assets20/58€571k€2.31M▲
Fixed assets21/28€314k€2.29M▲
Intangible fixed assets21€7k€3k▼
Tangible fixed assets22/27€6k€5k▼
Furniture and vehicles24€6k€5k▼
Financial fixed assets28€301k€2.28M▲
Current assets29/58€257k€16k▼
Amounts receivable after more than one year29€151k€0▼
Other amounts receivable291€151k€0▼
Amounts receivable within one year40/41€105k€16k▼
Trade receivables40€66k€5k▼
Other amounts receivable41€40k€10k▼
Cash at bank and in hand54/58€39€0▼
Equity and liabilities
Total equity and liabilities10/49€571k€2.31M▲
Equity10/15€-16k€1.64M▲
Contributions10/11€19k€19k=
Revaluation surpluses12-€2.28M
Profit (loss) carried forward14€-35k€-656k▼
Amounts payable17/49€588k€662k▲
Amounts payable after more than one year17€331k€397k▲
Financial debts170/4€331k€397k▲
Amounts payable within one year42/48€257k€265k▲
Financial debts43€144€0▼
Credit institutions430/8€144€0▼
Trade debts44€33k€59k▲
Suppliers440/4€33k€59k▲
Taxes, remuneration and social security45€74k€0▼
Taxes450/3€74k€0▼
Other amounts payable47/48€149k€206k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€5k€5k=
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€500k
Other operating charges640/8€51k€4k▼
Gross operating margin9900€120k€-92k▼
Operating profit (loss)9901€63k€-601k▼
Financial income75/76B€2k€3k▲
Recurring financial income75€2k€3k▲
Financial charges65/66B€28k€24k▼
Recurring financial charges65€28k€24k▼
Profit (loss) for the period before taxes9903€37k€-621k▼
Profit (loss) for the period9904€37k€-621k▼
Profit (loss) for the period to be appropriated9905€37k€-621k▼
Appropriation of the result
Profit (loss) to be appropriated9906€-35k€-656k▼
Profit (loss) brought forward from the previous period14P€-72k€-35k▲
The notes to these accounts (15 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
24-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial
Weakest financial yearnet €-621k ▼1772%
Net result drops to €-621k, the lowest in the series.
31-12
Financial
Equity above €1MEq €1.64M
Equity rises from €-16k to €1.64M.
18-06
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial
Liquidity triplescurrent ratio 1.00
Current ratio from 0.39 to 1.00; short-term debt falls from €492k to €257k.
02-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
30-11
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 122 days late
2022
31-12
Financial
Highest result since 2018net €250k ▲675%
Operating result €203k, net result €250k, both a record.
25-08
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 25 days late
2021
31-12
Financial
Back to profitnet €32k
Net result €32k after 3 loss-making years.
29-10
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 90 days late
18-02
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 202 days late
2019
30-09
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 61 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Gent · 1 establishment unit since 2017
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Karel van de Woestijnestraat 69000 GentGround area
907 m²
Building footprint
108 m²
Volume, LiDAR
573 m³
Parcel 44809I0539/00K003, Flanders · tallest building 12.6 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Karel van de Woestijnestraat 6, 9000 Gent
since 20172.268.932.542
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44809I0539/00K003 | Flanders | 907 m² | 1 · 108 m² | 12.6 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
RUMEXPERTS
BE 0742.532.822
Faimes · Eq €1,650,231
OTORINO
BE 0458.783.472
Waterloo · Eq €1,651,820
ReWind Therapeutics
BE 0682.626.216
Leuven · Eq €1,631,738
EUROFINS FOOD TESTING BELGIUM
BE 0831.186.664
Nazareth-De Pinte · Eq €1,590,773
Matthys Charlotte
BE 0835.964.410
Aalter · Eq €1,585,092
Of 761 companies in sector 72101 we hold annual accounts for 481. 270 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company (pre-2019)
Founded09-10-2017
Fiscal year end31-12
Activities, NACEBEL 2025
72101Research and development on biotechnology
21100Manufacture of basic pharmaceutical products and pharmaceutical preparations
Sources
Crossroads Bank for EnterprisesNational Bank · 8 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.